Full name
VALUEADD PHARMA (BY DR. MURPANI) SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Scientific research and development activities
82.92.Z - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 1,4 | 0,9 | -38 |
EBITDA | 0,8 | 1,4 | 1 | -26 |
Short time liabilities | 0 | 0 | 0 | -8,1 |
Equity capital | 0,7 | 1,3 | 0,8 | -38,2 |
Operating profit (EBIT) | 0,8 | 1,4 | 1 | -26,5 |
Assets | 0,8 | 1,3 | 0,8 | -37,5 |
Net profit (loss) | 0,7 | 1,3 | 0,8 | -38,4 |
Cash | 0,5 | 1,3 | 0,8 | -36,4 |
Net income from sale | 0,8 | 1,4 | 1,1 | -22,6 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | -8,2 |
Working assets | 0,7 | 1,3 | 0,8 | -35,9 |
Depreciation | 0 | 0 | 0 | -4,2 |
% | % | % | p.p. | |
Profitability of capital | 99,3 | 99,6 | 99,3 | -0,3 |
Equity capital to total assets | 94,2 | 97,4 | 96,2 | -1,2 |
Gross profit margin | 93,3 | 102,3 | 81,9 | -20,4 |
EBITDA Margin | 93,5 | 101,8 | 97,4 | -4,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 19 | 9 | 11 | 2 |
Current financial liquidity indicator | 15.40645980834961 | 37.29108810424805 | 26.06501007080078 | -11,2 |
Net dept to EBITDA | -0.6406456232070923 | -0.8947049379348755 | -0.7691797018051147 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane